Get the Stockscreener App
1.79
8.67%
-0.17
After Hours:
1.83
0.04
+2.23%
Biofrontera Inc stock is currently priced at $1.79, with a 24-hour trading volume of 56,757.
It has seen a -8.67% decreased in the last 24 hours and a +2.87% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.92 pivot point. If it approaches the $1.75 support level, significant changes may occur.
Previous Close:
$1.96
Open:
$1.94
24h Volume:
56,757
Market Cap:
$10.64M
Revenue:
$34.07M
Net Income/Loss:
$-20.13M
P/E Ratio:
-0.1046
EPS:
-17.1162
Net Cash Flow:
$-24.90M
1W Performance:
+5.92%
1M Performance:
+2.87%
6M Performance:
-63.44%
1Y Performance:
+200.84%
1D Range:
$1.73
$2.13
52W Range:
$0.3703
$12.99
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 Presidential Way, Suite 330, Woburn
Biofrontera Inc Stock (BFRI) Latest News
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
Benzinga
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks Investment Research
Biofrontera Inc Stock (BFRI) Financials Data
Biofrontera Inc (BFRI) Revenue 2024
BFRI reported a revenue (TTM) of $34.07 million for the quarter ending December 31, 2023, a +18.83% rise year-over-year.
Biofrontera Inc (BFRI) Net Income 2024
BFRI net income (TTM) was -$20.13 million for the quarter ending December 31, 2023, a -3,045% decrease year-over-year.
Biofrontera Inc (BFRI) Cash Flow 2024
BFRI recorded a free cash flow (TTM) of -$24.90 million for the quarter ending December 31, 2023, a -53.35% decrease year-over-year.
Biofrontera Inc (BFRI) Earnings per Share 2024
BFRI earnings per share (TTM) was -$12.92 for the quarter ending December 31, 2023, a -1,220% decline year-over-year.
About Biofrontera Inc
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.
2.43%
3.29%
Cap:
|
Volume (24h):